Subcutaneous implantation of estradiol pellets for postmenopausal disorders
Record ID 32012000171
English
Authors' recommendations:
Background Menopause, the cessation of menstruation, occurs at around age 50 years for most women. During this process, levels of the hormone estrogen fall dramatically and women may experience hot flashes, sleep disorders, mood swings, vaginal dryness, and decreased sexual desire. In addition, osteoporosis can occur if estrogen levels remain low for prolonged periods. These symptoms can be reduced or prevented by use of hormone replacement therapy (HRT), which typically involves administration of estrogen and progesterone via pills, skin patches, or gels.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=11409
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Drug Implants
- Estradiol
- Estrogen Replacement Therapy
- Menopause
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2011 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.